2020
DOI: 10.3390/molecules25204688
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of Cisplatin Cytotoxicity by Cu(II)–Mn(II) Schiff Base Tetradentate Complex in Human Oral Squamous Cell Carcinoma

Abstract: Oral squamous cell carcinoma (SCC) is one of the most predominant tumors worldwide and the present treatment policies are not enough to provide a specific solution. We aimed to assess the cytotoxic effect of Cu(II)–Mn(II) Schiff base tetradentate complex alone or in combination with cisplatin against squamous cell carcinoma cell line (SCCs) in vitro. Oral-derived gingival mesenchymal stem cells (GMSCs) were used as control. The cell viability was assessed by MTT assay. IC50 values were calculated. Evaluation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 34 publications
1
2
0
Order By: Relevance
“…This explains the down-regulation of anti-apoptotic gene activity in our result [ 29 ]. Apoptosis evaluated on cell line of oral squamous cell carcinoma claimed higher expression of BAX gene and p53 gene but the level of BCL2 anti-apoptosis gene was suppressed resembling our data [ 30 ].…”
Section: Discussionsupporting
confidence: 86%
“…This explains the down-regulation of anti-apoptotic gene activity in our result [ 29 ]. Apoptosis evaluated on cell line of oral squamous cell carcinoma claimed higher expression of BAX gene and p53 gene but the level of BCL2 anti-apoptosis gene was suppressed resembling our data [ 30 ].…”
Section: Discussionsupporting
confidence: 86%
“…All the complexes were more active than the free Schiff base ligand and, in particular, the higher cytotoxic activity was exerted by Cu, Co and Zn complexes (IC 50 = 61.1, 90.4 and 61.3 µg/mL on MCF-7 cells, respectively; IC 50 = 52.7, 60.6 and 51.9 µg/mL on HCT-116, respectively). Al-Serwi et al (2020) [47] studied a Cu(II)-Mn(II) Schiff base tetradentate complex alone or in combination with cisplatin against squamous cell carcinoma cell line (SCC) in vitro, adopting the oral-derived gingival mesenchymal stem cells (GMSCs) as control. The IC 50 values, obtained via MTT assay, were 1 µg/mL for cisplatin and 250 µM for the Schiff base complex 10) on both the cell lines.…”
Section: Antiproliferative Activity Of Schiff Bases Complexed With Transition Metalsmentioning
confidence: 99%
“…Schiff base ligand features the ability to easily regulate the molecular and electronic structures of complexes, and tune their physicochemical properties [ 40 ]. Hence, Schiff base is a type of versatile ligand, which has been widely applied in various fields such as biological [ 41 , 42 , 43 , 44 , 45 ], analytical [ 46 ], and catalytic [ 47 , 48 , 49 , 50 , 51 ] fields. Recently, many Schiff base complexes have been utilized in electrocatalysis for CO 2 reduction or water oxidation.…”
Section: Introductionmentioning
confidence: 99%